We are live on ! Find out more
ICPT

Intercept Pharmaceuticals, Inc.
ICPT

Delisted

ICPT was delisted on the 7th of November, 2023.

Back to rankings

57 hedge funds and large institutions have $399M invested in Intercept Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+57
Holders Change %
–
% of All Funds
1.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
57
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ICPT Hedge Fund Activity: Q2 2013 in Review

57 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q2 2013, worth a combined $399M.

Buyers outnumbered sellers: 57 funds opened new ICPT positions and 0 closed out — a net gain of 57 holders — while 0 added to existing stakes and 0 trimmed.

  • 57 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $399M of Intercept Pharmaceuticals, Inc. stock for Q2 2013.
  • 57 funds opened new Intercept Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +57 holders.

Based on aggregated 13F filings for Q2 2013.